July 28, 2021
RegenMed is helping to coordinate a multi-national Circle to study the efficacy and safety of the use of platelet-rich plasma (PRP) and minimally manipulated cellular products (SVF and BMAC) for the treatment of various MSK pathologies. The initiative is spearheaded by Circle Founder, Maksim Alekseevich Strakhov, Associate Professor of the Department of Traumatology, Orthopedics and Military Field Surgery, Russian National Research Medical University, and will involve scientific and clinical collaborators from the Union State (Russia and Belarus), North America, EU, and various other regions.
Benefits of joining this Circle include:
July 28, 2021
RegenMed is helping to coordinate a multi-national Circle to study the efficacy and safety of the use of platelet-rich plasma (PRP) and minimally manipulated cellular products (SVF and BMAC) for the treatment of various MSK pathologies. The initiative is spearheaded by Circle Founder, Maksim Alekseevich Strakhov, Associate Professor of the Department of Traumatology, Orthopedics and Military Field Surgery, Russian National Research Medical University, and will involve scientific and clinical collaborators from the Union State (Russia and Belarus), North America, EU, and various other regions.
Benefits of joining this Circle include: